Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

18 scientists move west to UK labs

2 min read
16:30UTC

DSIT reported on 5 June that 18 researchers had joined UK institutions via the £54m UKRI Global Talent Fund, recruited from Stanford, Yale, Columbia and elsewhere as American federal science budgets contract.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

British labs are pulling senior US-based scientists west as American federal science funding contracts.

DSIT reported on Friday 5 June that ten more researchers had joined UK institutions through the UKRI Global Talent Fund, a £54m pot administered by UK Research and Innovation (UKRI), taking the running total to 18. The named recruits left posts at Oregon State, Stanford, Columbia, UC San Diego, Yale and Tel Aviv. Professor Bryony DuPont moved from Oregon State to Strathclyde for AI in energy systems; Professor Laura Huckins left Yale for Bath to work on psychiatric genetics.⁠1

The timing tracks cuts to United States federal science budgets under the current administration, which have left researchers looking for stable funding abroad. These are placements, not promises: named people in named labs, expected to seed spinout activity over the coming years. Not every recruit founds a company, and the fund buys research capacity rather than guaranteed ventures.

The Advanced Research and Invention Agency (ARIA), the UK's high-risk research funder modelled on DARPA, reported a sharper conversion from its Encode fellowship, which pays researchers to spin out companies. Two proto-companies emerged from 18 fellows in four months, after which the government added £5m to double the cohort.

Britain signed a researcher-mobility deal with France in May, committing annual funding to early-career exchange. The Global Talent Fund and ARIA are the domestic side of the same effort, moving people as well as money into UK science.

Deep Analysis

In plain English

American universities and research labs have been cutting positions as the US federal science budget shrinks under the current administration. Some of those researchers are choosing to move abroad. The UK government set up a £54m fund specifically to recruit senior scientists from overseas. In the first wave, 18 researchers moved from Stanford, Columbia, Yale, and other American and Israeli institutions into UK university labs. Separately, ARIA, a UK agency modelled on the American DARPA programme, ran a four-month fellowship that explicitly allowed researchers to spend time founding companies. Two of the 18 fellows who went through the programme started proto-companies, which is an unusually high rate.

Deep Analysis
Root Causes

The US National Institutes of Health lost approximately $2bn in funding commitments in the first quarter of 2025 following Congressional budget reconciliation. The National Science Foundation faced a further 10% proposed cut in the 2026 federal budget request. These cuts affect postdoctoral and early-career researchers most severely, because their positions depend on grant renewal rather than tenure.

UK salary competitiveness has also improved relative to the US for mid-career researchers. The weak dollar (USD/GBP at 0.79 in May 2026) means a UK salary in sterling buys more in US-dollar terms than at any point since 2014, reducing the financial penalty of moving west.

ARIA's Encode fellowship operates differently from UKRI grant mechanisms: fellows receive a fixed-term stipend with explicit permission to spend time on company formation, removing the conflict-of-interest constraint that blocks most UK university researchers from serious commercialisation activity during their grant periods.

What could happen next?
  • Opportunity

    UK deep-tech companies now have a pool of recently-arrived senior US-trained scientists at UK institutions who are institutionally primed for commercial collaboration.

    Short term · Assessed
  • Risk

    If US federal science funding stabilises or recovers, the talent flow reverses: researchers recruited under time-limited packages may return to American institutions when their UK terms end.

    Medium term · Assessed
  • Consequence

    ARIA's 11% company-formation rate from the Encode cohort gives the agency a stronger case than any UK university technology transfer office for running the next wave of commercialisation funding.

    Short term · Assessed
Sources:GOV.UK / DSIT·GOV.UK / DSIT·GOV.UK / DSIT
Mentions:UKRI →Advanced Research and Invention Agency →DSIT →Oregon →DARPA →Tel Aviv →San Diego →France →United States →UKRI Global Talent Fund →ARIA's Encode fellowship →
First Reported In

Update #7 · OQC's £260m sets European quantum record

GOV.UK / DSIT· 7 Jun 2026
Read original →
Causes and effects
Caused by
UK and France sign science pact
UK-France researcher-mobility deal in May established the bilateral talent framework that runs alongside the UKRI Global Talent Fund domestic recruitment.
Occurred 29 May 2026
Read story →
This Event
18 scientists move west to UK labs
Named scientists placed in named UK labs show an active recruitment pipeline running west across the Atlantic, not a hypothetical one.
Led to
BBSRC backs 21 Fellows with £10m
UKRI's Global Talent Fund placed 18 international researchers in UK labs; BBSRC's 21 Fellows investment is the same talent-pipeline logic applied one rung earlier in the researcher career.
Occurred 18 Jun 2026
Read story →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.